Atrys Health S.A.: insider trades · Spain · CNMV CNMV:atrys-health-sa-88aa33 ES0105148003 ES ES · CNMV Mcap 203M€ Healthcare
Discover the full directors' dealings record of Atrys Health S.A., a publicly traded company based in Spain. Shares are listed on ES ES, under the authority of CNMV. Operating in the Healthcare sector, Atrys Health S.A. has published 7 insider filings. Market capitalisation: €203.1m. The latest transaction was reported on 15 April 2025 (Purchase). Among the most active insiders: Inveready Evergreen S.C.R. S.A.. The full history is accessible without an account.
Financial data FY ended December 2025 · cache
Analyst consensus
3 analysts · 4.00 € Target 4.83 €(+81%) 5.50 €
Income statement
Revenue 141.0 M€
Gross profit 61.3 M€ 44% margin
Net income −100.3 M€ -69.5% margin
Valuation
PER (forward) 25.3x
P/Book 1.3x
Beta 0.55
Balance sheet & cash
Market cap 203.1 M€
Total debt 257.9 M€
Free Cash Flow −14.1 M€
Debt / Equity 170%
Profitability & ownership
ROE -27.5%
ROA -1.2%
% insiders 54.6%
% institutions 5.6%
Last declaration on 15 April 2025
Declarations 7 total
Executives ● Purchase30 CNMV
€2m 770,470 shares @ €2.88 1.09% mcap 100.0% of flow ES0105148003⌘
CNMV:2025050885 · 10 Apr 2025
Ideal exit: 5 Jan 2026 (T+270) Executives ● Sale30 CNMV
€2m 728,541 shares @ €2.88 1.03% mcap 83.5% of flow ES0105148003⌘
CNMV:2025050627 · 10 Apr 2025
Executives ● Sale23 CNMV
€120,756 41,929 shares @ €2.88 0.059% mcap 100.0% of flow ES0105148003⌘
CNMV:2025050629 · 10 Apr 2025
Executives ● Purchase32 CNMV
€4,087 1,310 shares @ €3.12 0.0020% mcap 100.0% of flow ES0105148003⌘
CNMV:2024138176 · 27 Nov 2024
Ideal exit: 24 Aug 2025 (T+270) Executives ● Purchase14 CNMV
€66,586 19,134 shares @ €3.48 0.033% mcap 2.6% of flow ES0105148003⌘
CNMV:2024136121 · 22 Nov 2024
Ideal exit: 19 Aug 2025 (T+270) Executives ● Other18 CNMV
€222,231 36,018 shares @ €6.17 0.11% mcap 8.8% of flow ES0105148003⌘
CNMV:2023137111 · 23 Nov 2023
Executives ● Purchase16 CNMV
€126,491 32,023 shares @ €3.95 0.062% mcap 5.0% of flow ES0105148003⌘
CNMV:2023137112 · 23 Nov 2023
Ideal exit: 19 Aug 2024 (T+270)